human MIRN128 microRNA

RefSeq NR_029672 (miR-128a) and NR_029824 (miR-128b)

Also Known As:

MIRN128 microRNA, human; hsa-miRNA-128-3p; hsa-mir-128; hsa-mir-128-1; hsa-mir-128-2; hsa-mir-128a; hsa-mir-128b; miR-128, human; miR-128-3p, human; miR-128b, human; miR128-1, human; miR128-2, human; microRNA 128-1, human; microRNA 128-2, human; microRNA 128a, human; microRNA-128, human; mir-128-1, human; mir128a, human

Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleic Acids: 11752
  - RNA: 69704
    - Untranslated RNA: 2850
      - Small Untranslated RNA: 566
        MicroRNAs: 67298
        human MIRN128 microRNA: 4
    - Antisense RNA: 1599
      - MicroRNAs: 67298
        human MIRN128 microRNA: 4
- Antisense Elements (Genetics): 31
  - Antisense RNA: 1599
    - MicroRNAs: 67298
      - human MIRN128 microRNA: 4

Experts

1.	Bao, B: 1 article (03/2022)
2.	Chen, H: 1 article (03/2022)
3.	Chen, X: 1 article (03/2022)
4.	Ji, J: 1 article (03/2022)
5.	Liu, Z: 1 article (03/2022)
6.	Sai, W: 1 article (03/2022)
7.	Sun, Y: 1 article (03/2022)
8.	Wu, J: 1 article (03/2022)
9.	Wu, Y: 1 article (03/2022)
10.	Xiao, M: 1 article (03/2022)

Related Diseases

1.	Pancreatic Neoplasms (Pancreatic Cancer) 03/01/2022 - "In this study, we investigated the effects of exosomes extracted from human umbilical cord mesenchymal stem cells (HUCMSCs) carrying hsa-miRNA-128-3p on pancreatic cancer cells. " 03/01/2022 - "The effect of exosomes rich in hsa-miRNA-128-3p on pancreatic cancer cells was analyzed. " 03/01/2022 - "Hsa-miRNA-128-3p could be considered as a potential therapy for pancreatic cancer. " 03/01/2022 - "Based on existing experimental and database information, we selected Galectin-3, which is associated with pancreatic cancer, and the corresponding upstream hsa-miRNA-128-3p. "
2.	Laryngeal Neoplasms (Laryngeal Cancer) 01/01/2021 - "Therefore, hsa-miR-128a might be a novel target in laryngeal cancer treatment." 01/01/2021 - "Hsa-miR-128a was overexpressed in laryngeal cancer cell lines successfully. " 01/01/2021 - "The present study thus focused on the effect of hsa-miR-128a on pembrolizumab in laryngeal cancer cells as well as tried to elucidate the mechanisms that may mediate this effect. " 01/01/2021 - "Hsa-miR-128a boosted the effect of pembrolizumab on laryngeal cancer cells, perhaps via the p53 pathway. " 01/01/2021 - "Upregulating hsa-miR-128a Increased the Effects of Pembrolizumab on Laryngeal Cancer Cells via the p53 Pathway."
3.	Neoplasms (Cancer) 01/01/2020 - "We found that hsa-miR-128 and hsa-miR-223 regulate genes mediating lipid signalling and cholesterol metabolism, cancer drug resistance and breast cancer genes. "
4.	Carotid Artery Diseases 01/01/2022 - "Therefore, FBLN5 may play an important role in carotid atherosclerosis via hsa-mir-128 and hsa-mir-532-3p as well as become an essential target for treatment."
5.	Carcinoma (Carcinomatosis) 03/01/2022 - "Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-3."

Related Drugs and Biologics

1.	pembrolizumab
2.	Galectin 3 (LGALS3)
3.	Lipids
4.	Cholesterol

Related Therapies and Procedures

1.	Therapeutics